Molnupiravir
Catalog No. A22165
Molnupiravir (EIDD-2801, MK-4482) is an orally bioavailable prodrug of the ribonucleoside analog β-d-N4-hydroxycytidine (NHC; EIDD-1931) with broad-spectrum antiviral activity against SARS-CoV-2, MERS-CoV, SARS-CoV, and the causative agent of COVID-19.
Catalog Num | A22165 |
---|---|
M. Wt | 329.3 |
Formula | C13H19N3O7 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 2349386-89-4 |
Synonyms | EIDD-2801; MK-4482 |
SMILES | O[C@@H]([C@H]([C@H](N1C(N/C(C=C1)=N/O)=O)O2)O)[C@H]2COC(C(C)C)=O |
Molnupiravir (EIDD-2801, MK-4482) is an orally bioavailable prodrug of the ribonucleoside analog β-d-N4-hydroxycytidine (NHC; EIDD-1931) with broad-spectrum antiviral activity against SARS-CoV-2, MERS-CoV, SARS-CoV, and the causative agent of COVID-19.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 30.37 mL | 151.84 mL | 303.67 mL |
0.5 mM | 6.07 mL | 30.37 mL | 60.73 mL |
1 mM | 3.04 mL | 15.18 mL | 30.37 mL |
5 mM | 0.61 mL | 3.04 mL | 6.07 mL |
*The above data is based on the productmolecular weight 329.3. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.